Pre-clinical stage company advancing multiple therapeutic modalities against novel cancer targets.
Inversion Therapeutics
Oncology
Total Addressable Market
Red Tree Board Member(s)
Red Tree Board Member
Jeremy Caldwell, Ph.D.
Affiliated with Red Tree SAB Member
Red Tree Participation
Led seed round